Advertisement
U.S. Markets close in 3 hrs 23 mins

LakeShore Biopharma Co., Ltd (LSB)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W
1.9800-0.1900 (-8.76%)
As of 12:24PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close2.1700
Open1.9900
Bid3.7500 x 100
Ask3.7700 x 100
Day's Range1.9800 - 1.9900
52 Week Range1.8800 - 11.2000
Volume769
Avg. Volume20,505
Market Cap37.78M
Beta (5Y Monthly)0.74
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • TipRanks

    LakeShore Biopharma Advances with Rabies Vaccine Trial

    LakeShore Biopharma (LSB) has released an update. LakeShore Biopharma has received approval for a Phase III clinical trial in China to test a simplified four-dose regimen of its YSJA rabies vaccine, potentially enhancing patient adherence and reducing financial burdens. The trial aims to validate the vaccine’s safety and effectiveness compared to the current standard regimen, promising greater flexibility for patients and healthcare providers. This development could strengthen LakeShore Biopharm

  • Simply Wall St.

    LakeShore Biopharma Insider Ups Holding By 3,083% During Year

    Viewing insider transactions for LakeShore Biopharma Co., Ltd's ( NASDAQ:LSB ) over the last year, we see that insiders...